Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chinese Herbs + Chemotherapy in Advanced NSCLC
NCT02737735Phase 1Unknown
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Mar 2016
- Primary completion
- Dec 2019
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial in non-small cell lung cancer (NSCLC) (2 arms), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Primary endpoints: Overall Survival Rate at 36 months and Progression-Free Survival Rate at 36 months. Status: unknown.
02
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02737735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02737735.